Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OligoG in CF Patients With Burkholderia Infection
NCT02453789Phase 2Completed
- Sponsor
- AlgiPharma
- Start
- Feb 2015
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
A Phase 2 trial of alginate oligosaccharide in cystic fibrosis (CF), Burkholderia infection, sponsored by AlgiPharma. Started Feb 2015; status: completed.
02
Drugs
alginate oligosaccharide
03
Conditions
cystic fibrosis (CF)Burkholderia infection
Beyond the preview
Go deeper on NCT02453789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453789.